The oligonucleotide synthesis market has been growing significantly owing to increasing online and strong pipelines of the oligonucleotide, the growing burden of chronic diseases and rising consolidation of the market. However, lack of regulatory scenario for the oligonucleotide, challenging drug delivery technique and complex therapeutics classification owing to a large range of oligonucleotides is the restraining factor that hampers the market growth.